Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 587

1.

Complement activation in diseases presenting with thrombotic microangiopathy.

Meri S.

Eur J Intern Med. 2013 Sep;24(6):496-502. doi: 10.1016/j.ejim.2013.05.009. Epub 2013 Jun 4. Review.

PMID:
23743117
2.

The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.

Phillips EH, Westwood JP, Brocklebank V, Wong EK, Tellez JO, Marchbank KJ, McGuckin S, Gale DP, Connolly J, Goodship TH, Kavanagh D, Scully MA.

J Thromb Haemost. 2016 Jan;14(1):175-85. doi: 10.1111/jth.13189. Epub 2016 Jan 11.

3.
4.

Atypical hemolytic uremic syndrome (aHUS): making the diagnosis.

Laurence J.

Clin Adv Hematol Oncol. 2012 Oct;10(10 Suppl 17):1-12. Review.

PMID:
23187605
5.

Thrombotic microangiopathy without renal involvement: two novel mutations in complement-regulator genes.

Peyvandi F, Rossio R, Ferrari B, Lotta LA, Pontiggia S, Ghiringhelli Borsa N, Pizzuti M, Donadelli R, Piras R, Cugno M, Noris M.

J Thromb Haemost. 2016 Feb;14(2):340-5. doi: 10.1111/jth.13210. Epub 2016 Feb 1.

PMID:
26613809
6.

Genetics of atypical hemolytic uremic syndrome (aHUS).

Rodríguez de Córdoba S, Hidalgo MS, Pinto S, Tortajada A.

Semin Thromb Hemost. 2014 Jun;40(4):422-30. doi: 10.1055/s-0034-1375296. Epub 2014 May 5. Review.

PMID:
24799305
7.

Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.

Maga TK, Nishimura CJ, Weaver AE, Frees KL, Smith RJ.

Hum Mutat. 2010 Jun;31(6):E1445-60. doi: 10.1002/humu.21256.

PMID:
20513133
8.

[Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].

Frémeaux-Bacchi V, Fakhouri F, Roumenina L, Dragon-Durey MA, Loirat C.

Rev Med Interne. 2011 Apr;32(4):232-40. doi: 10.1016/j.revmed.2009.09.039. Epub 2011 Mar 3. French.

9.

Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.

Laurence J, Haller H, Mannucci PM, Nangaku M, Praga M, Rodriguez de Cordoba S.

Clin Adv Hematol Oncol. 2016 Nov;14 Suppl 11(11):2-15. Review.

PMID:
27930620
10.

STEC-HUS, atypical HUS and TTP are all diseases of complement activation.

Noris M, Mescia F, Remuzzi G.

Nat Rev Nephrol. 2012 Nov;8(11):622-33. doi: 10.1038/nrneph.2012.195. Epub 2012 Sep 18. Review.

PMID:
22986360
11.

Alternative complement pathway assessment in patients with atypical HUS.

Roumenina LT, Loirat C, Dragon-Durey MA, Halbwachs-Mecarelli L, Sautes-Fridman C, Fremeaux-Bacchi V.

J Immunol Methods. 2011 Feb 28;365(1-2):8-26. doi: 10.1016/j.jim.2010.12.020. Epub 2011 Jan 6. Review.

PMID:
21215749
12.

Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome.

Frimat M, Tabarin F, Dimitrov JD, Poitou C, Halbwachs-Mecarelli L, Fremeaux-Bacchi V, Roumenina LT.

Blood. 2013 Jul 11;122(2):282-92. doi: 10.1182/blood-2013-03-489245. Epub 2013 May 21.

13.

Atypical hemolytic uremic syndrome.

Kavanagh D, Goodship TH.

Curr Opin Hematol. 2010 Sep;17(5):432-8. doi: 10.1097/MOH.0b013e32833cae86. Review.

PMID:
20613506
14.

Complement activation in thrombotic microangiopathy.

Karpman D, Tati R.

Hamostaseologie. 2013 May 29;33(2):96-104. doi: 10.5482/HAMO-12-12-0025. Epub 2013 Feb 15. Review.

PMID:
23411690
15.

Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.

Skerka C, Licht C, Mengel M, Uzonyi B, Strobel S, Zipfel PF, Józsi M.

Mol Immunol. 2009 Sep;46(14):2801-7. doi: 10.1016/j.molimm.2009.05.018. Epub 2009 Jul 28. Review.

PMID:
19640589
16.

[Atypical HUS caused by complement-related abnormalities].

Yoshida Y, Matsumoto M.

Rinsho Ketsueki. 2015 Feb;56(2):185-93. doi: 10.11406/rinketsu.56.185. Review. Japanese.

PMID:
25765799
17.

Natural history of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.

Wada H, Matsumoto T, Yamashita Y.

Semin Thromb Hemost. 2014 Nov;40(8):866-73. doi: 10.1055/s-0034-1395154. Epub 2014 Nov 6. Review.

PMID:
25377323
18.

Thrombotic microangiopathies.

Rosove MH.

Semin Arthritis Rheum. 2014 Jun;43(6):797-805. doi: 10.1016/j.semarthrit.2013.11.004. Epub 2013 Nov 16. Review.

PMID:
24360024
19.

The molecular biology of thrombotic microangiopathy.

Tsai HM.

Kidney Int. 2006 Jul;70(1):16-23. Epub 2006 May 31. Review.

20.

Diagnosis and management of complement mediated thrombotic microangiopathies.

Cataland SR, Wu HM.

Blood Rev. 2014 Mar;28(2):67-74. doi: 10.1016/j.blre.2014.01.003. Epub 2014 Jan 31. Review.

PMID:
24534133

Supplemental Content

Support Center